AE Wealth Management LLC Increases Investment in Zoetis
June 30, 2023
☀️Trending News
AE Wealth Management LLC recently announced that it has increased its investment in Zoetis Inc ($NYSE:ZTS)., a global animal health company. This news was reported by Defense World. Zoetis Inc. is a leading animal health company committed to developing and commercializing innovative products and services to prevent and treat disease in livestock and companion animals. The company’s portfolio includes products sold through prescription and over-the-counter channels, biologicals, vaccines, flea and tick control products, medicated feed additives, diagnostic products, genetic tests, and a variety of services.
Zoetis also offers a range of animal health-related products and services, including veterinary software solutions, veterinary laboratory diagnostics, and consulting services. With this expanded investment from AE Wealth Management LLC, Zoetis Inc. is poised to continue to grow and develop its animal health offerings.
Stock Price
On Thursday, AE Wealth Management LLC made a significant investment in Zoetis Inc. By the end of the trading day, Zoetis Inc’s stock had opened at $168.6 and closed at $171.9, representing a 1.6% increase in its value from the previous closing price of 169.1. This demonstrates AE Wealth Management LLC’s confidence in the company and its potential for growth. The company remains well-positioned to benefit from its investments, both in terms of short-term gains and long-term stability. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Zoetis Inc. More…
| Total Revenues | Net Income | Net Margin |
| 8.09k | 2.07k | 26.9% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Zoetis Inc. More…
| Operations | Investing | Financing |
| 2.15k | -981 | -2.16k |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Zoetis Inc. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 13.75k | 9.26k | 9.72 |
Key Ratios Snapshot
Some of the financial key ratios for Zoetis Inc are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 8.5% | 10.4% | 35.3% |
| FCF Margin | ROE | ROA |
| 18.0% | 40.1% | 13.0% |
Analysis
GoodWhale recently analyzed the financials of ZOETIS INC, and the results are encouraging. Our Star Chart gave it a high health score of 9/10, indicating that it is capable to sustain future operations in times of crisis. We categorize ZOETIS INC as a ‘rhino’, which means that the company has achieved moderate revenue and earnings growth. Considering the financials of ZOETIS INC, it is likely to attract investors who are looking for a strong dividend yield and profitability. Its asset and growth figures are rated as medium, which may be desirable for those who prioritize safety and stability. More…
Peers
Zoetis Inc. is a global animal health company that develops, manufactures, and markets a wide range of veterinary products. The company’s products include vaccines, parasiticides, pharmaceuticals, diagnostics, and biologics. Zoetis Inc. has a broad portfolio of products that are used in the prevention, treatment, and control of disease in animals. The company’s competitors include BioGaia AB, Krka d.d., and Phibro Animal Health Corp.
– BioGaia AB ($OTCPK:BIOGY)
Biogaia is a Swedish biotech company that markets probiotic products for infants, children, and adults. The company’s products are based on the lactic acid bacterium Lactobacillus reuteri, which is found naturally in the human gastrointestinal tract. Biogaia’s products are sold in over 60 countries worldwide.
Biogaia’s market cap is 800.05M as of 2022. The company has a Return on Equity of 10.86%. Biogaia’s products are based on the lactic acid bacterium Lactobacillus reuteri, which is found naturally in the human gastrointestinal tract. Biogaia’s products are sold in over 60 countries worldwide.
– Krka d.d. ($LTS:0HLK)
Krka d.d. is a Slovenian pharmaceutical company. It is the largest pharmaceutical company in Slovenia and one of the largest in the Balkans. The company was founded in 1959 and is headquartered in Novo mesto. Krka d.d. has a market cap of 2.77B as of 2022 and a Return on Equity of 12.85%. The company’s main products are prescription drugs, over-the-counter drugs, and medical devices.
– Phibro Animal Health Corp ($NASDAQ:PAHC)
Phibro Animal Health Corporation is a diversified animal health and specialty ingredients company with products in over 100 countries. The company’s products are sold through veterinarians, distributors, and feed stores. Phibro Animal Health Corporation’s mission is to improve the health and productivity of animals. The company’s products are used in a variety of animals, including cattle, swine, poultry, and aquaculture. Phibro Animal Health Corporation’s products are designed to improve the health and productivity of animals while providing a safe and healthy environment for them to live in.
Summary
AE Wealth Management LLC recently increased their holdings in Zoetis Inc., a leading animal health company. This move highlights the potential of investing in the company. Zoetis Inc. offers a wide array of products and services for livestock and pets, with a portfolio of medicines, vaccines, and diagnostic products. They also specialize in genetic testing and biodevelopment.
Analysts have cited Zoetis’ global reach and strong financial performance as reasons to invest in the company. They also noted that Zoetis has been aggressively expanding its portfolio of new products and services to stay ahead of the competition.
Related Posts
Recent Posts
